NDC 87081-467

Desferal 500 mg per 5 mL injection, powder, for solution

On the label: Mitem Pharma.

Germany: 2Switzerland: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Excella GmbH & Co. KGFeucht, GermanyMakes the active ingredient and tests it Problems found, fixed voluntarilyOct 19, 2022 · 7 inspections
Novartis Pharma Stein AGStein, SwitzerlandMakes it, tests it and packages it Problems found, fixed voluntarilyJul 19, 2024 · 9 inspections
Wasserburger Arzneimittelwerk GmbHWasserburg a Inn, GermanyMakes it, tests it and packages it No problems foundMay 2, 2024 · 5 inspections
Labor LS SE & Co. KGBad Bocklet, GermanyTests it Problems found, fixed voluntarilyDec 14, 2022 · 6 inspections, 1 with FDA action
Novartis Pharma AGBasel, SwitzerlandTests it Problems found, fixed voluntarilyDec 18, 2025 · 10 inspections
Packaging Coordinators, LLCPhiladelphia, PA, United StatesPackages it Problems found, fixed voluntarilyJan 31, 2025 · 6 inspections
Pharmanalytica SALocarno, SwitzerlandTests it No problems foundMar 29, 2023 · 4 inspections
SGS Institut Fresenius GmbHBerlin, GermanyTests it No problems foundNov 23, 2023 · 6 inspections
SGS Institut Fresenius GmbHTaunusstein, GermanyTests it Problems found, fixed voluntarilyFeb 21, 2025 · 4 inspections
SGS International Services Laboratory (ISL) LimitedCork, IrelandTests it No problems foundApr 14, 2022 · 3 inspections
Solvias AGKaiseraugst, SwitzerlandTests it Problems found, fixed voluntarilyAug 7, 2025 · 10 inspections

Product details

Generic drug
Deferoxamine: every company that makes it
Form
injection, powder, for solution, intravenous; subcutaneous
Strength
500 mg per 5 mL
Approval
NDA NDA016267
On the market since
Apr 2, 1968
Package NDCs
87081-467-91
Official label
DailyMed (National Library of Medicine), updated Jul 2, 2025

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?